Synthesis and anti-melanogenic effects of lipoic acid-polyethylene glycol ester
Open Access
- 1 July 2008
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 60 (7), 863-870
- https://doi.org/10.1211/jpp.60.7.0007
Abstract
To develop a new potent anti-melanogenic agent, we have conjugated lipoic acid (LA) to poly (ethylene) glycol (PEG) of molecular weight 2000 and examined the effects on inhibition of tyrosinase activity and melanin synthesis in B16F10 melanoma cells. The water-soluble LA-PEG 2000 was synthesized from LA and methylated PEG by an esterification reaction in the presence of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide. Synthetic LA-PEG 2000 was confirmed by IR and 1H-NMR spectroscopy. The new conjugate is a highly water-soluble molecule, which has lower cell cytotoxicity than LA. Treatment with LA-PEG 2000 significantly suppressed the biosynthesis of melanin by up to 63% at 0.25 mm and reduced tyrosinase activity by up to 80% at 0.50 mm in B16F10 melanoma cells. Furthermore, Western blot and RT-PCR studies indicated that treatment with LA-PEG 2000 decreased the level of tyrosinase, which is a melanogenic enzyme. Taken together, these results suggest that LA-PEG 2000 may inhibit melanin biosynthesis by down-regulating levels and expression of tyrosinase activity. Therefore, LA-PEG 2000 can be used effectively as a new agent to inhibit mel-anogenesis, with lower cytotoxicity than LA (parent molecule) in B16F10 melanoma cells.Keywords
This publication has 29 references indexed in Scilit:
- Tethered Bilayer Lipid Membranes Based on Monolayers of Thiolipids Mixed with a Complementary Dilution Molecule. 1. Incorporation of Channel PeptidesLangmuir, 2005
- Chemical and Instrumental Approaches to Treat HyperpigmentationPigment Cell Research, 2003
- Effect of pegylation on pharmaceuticalsNature Reviews Drug Discovery, 2003
- Novel lipoic acid analogues that inhibit nitric oxide synthaseBioorganic & Medicinal Chemistry Letters, 2002
- BMP-2 stimulates tyrosinase gene expression and melanogenesis in differentiated melanocytes.Pigment Cell Research, 2001
- PEG drugs: an overviewJournal of Controlled Release, 2001
- Melanogenesis by tyrosinase action on 3,4‐dihydroxyphenylalanine (DOPA) in the presence of polyethylene glycol: a matrix‐assisted laser desorption/ionization mass spectrometric investigationRapid Communications in Mass Spectrometry, 2001
- Biochemical Control of Melanogenesis and Melanosomal OrganizationJournal of Investigative Dermatology Symposium Proceedings, 1999
- A review of skin ageing and its medical therapyBritish Journal of Dermatology, 1996
- Melanocyte-stimulating hormone—mimetic action of the phenothiazinesJournal of Pharmacy and Pharmacology, 1978